Search results
QIAGEN (QGEN) Debuts dPCR Microbial DNA Detection Assays
Zacks· 10 hours agoThe new assays are available on the GeneGlobe research platform and are designed to target a wide range of pathogens responsible for tropical diseases, sexually transmitted infections (STIs) ...
QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to...
Morningstar· 5 days agoQIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today released its 2023 Sustainability Report which underscores the company’s commitment to Environmental, Social, and Governance ...
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput...
Morningstar· 4 days agoVenlo, the Netherlands, and Redwood City, California, June 13, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the release of a ...
Qiagen (NYSE:QGEN) Short Interest Down 15.6% in May
ETF DAILY NEWS· 2 days agoQiagen (NYSE:QGEN – Get Free Report) saw a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 2,590,000 shares, a drop of ...
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious...
Morningstar· 6 days agoQIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of 35 new wet-lab tested digital PCR Microbial DNA Detection Assays for its digital PCR (dPCR ...
Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing
Zacks via Yahoo Finance· 5 days agoThe panel includes 39 conditions and screens up to 272 genes associated with severe inherited...
Wellcome Sanger Benchmarking Study Highlights Suitable Enzymes for NGS Library Amplification
GenomeWeb News· 3 days agoResearchers from the Wellcome Sanger Institute have benchmarked over 20 high-fidelity enzymes for next-generation sequencing library amplification, shedding light on the best PCR polymerases ...
Myriad Genetics, GSK Collaborate on International Ovarian Cancer Testing Program
GenomeWeb News· 6 days agoGSK will provide financial support for a program to expand access to Myriad's MyChoice tests for patients with high-grade serous ovarian cancer.
